Sanofi said its amlitelimab drug confirmed its potential to treat eczema in patients 12 years and older in two late-phase ...
Kyowa Kirin will file for rocatinlimab’s US approval, which was once Amgen’s most late-stage pipeline candidate.
Topical steroid withdrawal occurs when the body becomes addicted to, and physically dependent on, topical corticosteroids, ...
The decision comes more than a year after disappointing initial Phase 3 results and casts further doubt on a class of ...
KENS-TV San Antonio on MSN

Big breakthrough in treatment for eczema

Do you have it? If you don’t, someone you know probably does. There’s a new treatment you’ve got to know about!
Jia Patrick told Newsweek that living with TSW has been "a truly harrowing experience" that will take a long time to recover ...
"I always felt like there was just something wrong with me," Michelle Smith told Newsweek, after years of itchy skin.
Researchers are using toy-inspired technology to help relieve eczema, a painful, itchy condition affecting tens of millions in the U.S.
7 eczema medications to help for better skin control Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes ...
By Bhanvi Satija LONDON, Feb 2 (Reuters) - French drugmaker Sanofi said on Monday that its experimental genetic disorder ...
The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
“Whilst most cases of impetigo are not serious and can heal on their own, leaving impetigo untreated can lead to more serious ...